正業科技(300410.SZ)中標瑞浦能源全自動X-Ray電芯檢測機項目
格隆匯 2 月 4日丨正業科技(300410.SZ)公佈,公司於近日收到瑞浦能源出具的《定點(中標)通知書》,公司中標瑞浦能源二期、三期工廠全自動X-Ray電芯檢測機招標項目,此次中標項目涉及設備共分四批,第一批設備成交金額1862.50萬元(含税),預計四批設備成交金額合計7450萬元(含税)。
截至本公吿披露日,公司與瑞浦能源就此次中標項目設備尚未簽訂正式的設備購銷合同。此次中標項目涉及設備共分四批,公司與瑞浦能源已就此次中標項目涉及的第一批設備的設備數量、成交價格、付款方式等進行確認,第一批設備成交金額1862.50萬元(含税),此次中標項目涉及的第二、三、四批設備中標數量原則上各批次均參照第一批中標數量,預計四批設備成交金額合計7450萬元(含税)。瑞浦能源根據第一批中標設備交付及運行等情況保留對後續批次進行調整的權利。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.